A5113346162- Facial Trauma and Fracture Management
- Cardiac Arrest and Resuscitation
- Cutaneous Melanoma Detection and Management
- Airway Management and Intubation Techniques
- Congenital Heart Disease Studies
- Melanoma and MAPK Pathways
- Sleep and Work-Related Fatigue
- Optimism, Hope, and Well-being
- Assisted Reproductive Technology and Twin Pregnancy
- Surgical site infection prevention
- Nonmelanoma Skin Cancer Studies
- Healthcare professionals’ stress and burnout
- Head and Neck Surgical Oncology
- Trauma Management and Diagnosis
The University of Texas Southwestern Medical Center
2025
Oregon Health & Science University
2025
Our Lady of the Lake Regional Medical Center
2025
St. John Medical Center
2025
Methodist Dallas Medical Center
2025
Clinical Research Institute
2024
O'Brien Institute
2001
London Health Sciences Centre
1997-1998
BACKGROUND Craniofacial trauma affects approximately 3 million individuals in the United States annually. Historically, low overall data quality and inadequate sample size have limited development of clinical practice guidelines for prophylactic antibiotic use facial fractures. We sought to examine current patterns effects antibiotics non-operative METHODS A prospective analysis adult patients with nonoperative fractures was conducted across 19 centers from January 2022 December 2023....
Background Acute pain due to rib fractures causes significant in-hospital morbidity and impacts patients’ quality of life after discharge. Intraoperative transthoracic cryoneurolysis the intercostal nerves can improve postoperative pain; however, non-surgical patients are provided limited analgesia options. Here, we describe our experience with a bedside cryoanalgesia technique for management acute fracture pain. Methods Five at single level I trauma center completed nerve (INC) using...
S296 The purpose of this study was to compare analgesia following local infiltration bupivacaine vs. placebo during bilateral reduction mammoplasty and assess the feasibility same day discharge. METHODS: After IRB approval informed written consent 40 patients (20 per group) scheduled for elective (BRM) were randomized receive either 0.25% mL (B) or a saline (P). All received morphine 15 mg, dimenhydrinate 50 metoclopramide 10 nitrous oxide, mivacurium (without reversal) propofol both...